These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38900156)

  • 1. Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3.
    Feng Y; Qian R; Cui D; Luan J; Xu M; Wang L; Li R; Wu X; Chang C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):312. PubMed ID: 38900156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation.
    Brown L; Waseem A; Cruz IN; Szary J; Gunic E; Mannan T; Unadkat M; Yang M; Valderrama F; O'Toole EA; Wan H
    Oncogene; 2014 May; 33(18):2363-74. PubMed ID: 23752190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion.
    Guo AK; Itahana Y; Seshachalam VP; Chow HY; Ghosh S; Itahana K
    Br J Cancer; 2021 Jan; 124(1):299-312. PubMed ID: 33144694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway.
    Chen YJ; Lee LY; Chao YK; Chang JT; Lu YC; Li HF; Chiu CC; Li YC; Li YL; Chiou JF; Cheng AJ
    PLoS One; 2013; 8(5):e64088. PubMed ID: 23737966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.
    Kang N; Wang Y; Guo S; Ou Y; Wang G; Chen J; Li D; Zhan Q
    BMC Cell Biol; 2018 Aug; 19(1):16. PubMed ID: 30126368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung.
    Savci-Heijink CD; Kosari F; Aubry MC; Caron BL; Sun Z; Yang P; Vasmatzis G
    Am J Pathol; 2009 May; 174(5):1629-37. PubMed ID: 19342368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
    Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ
    Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
    Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
    J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
    Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
    Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma.
    Fang WK; Chen B; Xu XE; Liao LD; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
    Acta Histochem; 2014 Jun; 116(5):803-9. PubMed ID: 24630396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An N
    Uddin MB; Roy KR; Hosain SB; Khiste SK; Hill RA; Jois SD; Zhao Y; Tackett AJ; Liu YY
    Biochem Pharmacol; 2019 Feb; 160():134-145. PubMed ID: 30578766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.
    Arjonen A; Kaukonen R; Mattila E; Rouhi P; Högnäs G; Sihto H; Miller BW; Morton JP; Bucher E; Taimen P; Virtakoivu R; Cao Y; Sansom OJ; Joensuu H; Ivaska J
    J Clin Invest; 2014 Mar; 124(3):1069-82. PubMed ID: 24487586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.
    Shakya R; Tarulli GA; Sheng L; Lokman NA; Ricciardelli C; Pishas KI; Selinger CI; Kohonen-Corish MRJ; Cooper WA; Turner AG; Neilsen PM; Callen DF
    Oncogene; 2017 Aug; 36(31):4469-4480. PubMed ID: 28368395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YTHDF1 Promotes Cyclin B1 Translation through m
    Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of desmogleins 1-3 and their clinical impacts on human lung cancer.
    Saaber F; Chen Y; Cui T; Yang L; Mireskandari M; Petersen I
    Pathol Res Pract; 2015 Mar; 211(3):208-13. PubMed ID: 25468811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.
    Fang WK; Gu W; Liao LD; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
    Asian Pac J Cancer Prev; 2014; 15(2):871-6. PubMed ID: 24568510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma.
    Ormanns S; Altendorf-Hofmann A; Jackstadt R; Horst D; Assmann G; Zhao Y; Bruns C; Kirchner T; Knösel T
    Br J Cancer; 2015 Nov; 113(10):1460-6. PubMed ID: 26469831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.